$ITRM News

What's Going On With Iterum Therapeutics Stock Monday?

HC Wainwright & Co. Downgrades Iterum Therapeutics to Neutral

Trading Halt: Halt status updated at 10:15:00 AM ET: Quotation Resumption: News and Resumption Times

Iterum Therapeutics Submits Petition In Ireland's High Court To Wind Up Operations

Trading Halt: Halted at 9:17:21 a.m. ET - Trading Halt: Halt News Pending

Iterum Therapeutics Provides Business Update

Iterum Therapeutics Reaches Rebate Milestone, Obtains Patent

Iterum Therapeutics Provides Business Update

Iterum Therapeutics shares are trading higher after the company announced it expanded ORLYNVAH access, secured a Medicare Part D milestone and strengthened its patent portfolio.

Iterum Therapeutics Expands ORLYNVAH Access, Secures Medicare Part D Deal, and Strengthens Patent Portfolio

Iterum Therapeutics PLC (ITRM) Q3 2025 Earnings Call Highlights: Launch Success and Financial ...

Iterum Therapeutics Reports Third Quarter 2025 Financial Results

Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript

Iterum Therapeutics Q3 Adj. EPS $(0.16) Misses $(0.11) Estimate, Sales $390.000K

A Glimpse of Iterum Therapeutics's Earnings Potential

Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025

Analysts Expect Breakeven For Iterum Therapeutics plc (NASDAQ:ITRM) Before Long

Iterum Therapeutics to Present Data at IDWeek 2025

Iterum Therapeutics sees cash runway into 2026

Iterum Therapeutics Provides Business Update